Inicio・Lista de Acciones・Quanterix Corp

Quanterix Corp

Cerrado

SectorSanidad

4.01 4.97

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

3.82

Máximo

4.03

Métricas clave
By Trading Economics
Ingresos	5.6M -18M
Ventas	-7.4M 36M
BPA	0.16
Margen de beneficios	-48.17
Empleados	450
EBITDA	5.5M -11M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+4.44% upside

Dividendos
By Acuity
Próximas Ganancias	10 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	16M 175M
Apertura anterior	-0.96
Cierre anterior	4.01

Noticias sobre sentimiento de mercado

By Acuity

50%

168 / 340 Clasificación en Healthcare

Quanterix Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 ago 2026, 19:23 UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

3 ago 2026, 19:26 UTC

Quanterix Corp shares are higher today, tracking broader market gains amid rising confidence in tech stocks and falling energy prices.

31 jul 2026, 19:46 UTC

Quanterix Corp shares are higher today, reflecting a modest gain since Thursday's close. The stock is near the lower end of its one-month range.

30 jul 2026, 19:59 UTC

Quanterix Corp is trading higher amid a broader recovery in tech shares. The asset has shown notable volatility, pulling back from earlier session highs.

29 jul 2026, 19:43 UTC

Macro Event

Quanterix Corp's shares are lower today amid broader market declines, reflecting heightened volatility following the Federal Reserve's decision to maintain interest rates.

28 jul 2026, 20:06 UTC

Quanterix Corp shares are declining amid broader market weakness, with the Nikkei 225 dropping significantly due to concerns over AI spending and semiconductor competition.

27 jul 2026, 16:06 UTC

Quanterix Corp shares are higher today, following a strong opening. No specific news was identified to explain the price movement.

24 jul 2026, 19:53 UTC

Quanterix Corp shares are lower today, continuing a decline since Thursday amid broader market uncertainty from oil volatility and new U.S. tariffs.

22 jul 2026, 19:36 UTC

Quanterix Corp shares are lower in Wednesday's session, continuing a decline since Tuesday's close amid rising crude oil prices and market concerns.

21 jul 2026, 21:26 UTC

Quanterix Corp shares are higher in after-market hours, reflecting positive trading momentum. Broader market strength may be influencing sentiment following the close.

20 jul 2026, 19:46 UTC

Quanterix Corp shares are higher today amid positive market sentiment and a notable rise in the Hang Seng 50 Index, despite no specific company news.

Comparación entre iguales

Cambio de precio

Quanterix Corp previsión

Precio Objetivo

By TipRanks

4.44% repunte

Estimación a 12 Meses

Media 4 USD 4.44%

Máximo 4 USD

Mínimo 4 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Quanterix Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

1 ratings

Comprar

Mantener

Vender

De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para Quanterix Corp Dist en los últimos 3 meses.

Sentimiento

By Acuity

168 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.